nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Spironolactone—dilated cardiomyopathy	0.425	1	CrCtD
Medroxyprogesterone Acetate—PGR—Spironolactone—dilated cardiomyopathy	0.0697	0.29	CbGbCtD
Medroxyprogesterone Acetate—SHBG—Spironolactone—dilated cardiomyopathy	0.0669	0.278	CbGbCtD
Medroxyprogesterone Acetate—AR—Spironolactone—dilated cardiomyopathy	0.056	0.233	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Spironolactone—dilated cardiomyopathy	0.0356	0.148	CbGbCtD
Medroxyprogesterone Acetate—Eplerenone—Spironolactone—dilated cardiomyopathy	0.0337	0.121	CrCrCtD
Medroxyprogesterone Acetate—Dydrogesterone—Spironolactone—dilated cardiomyopathy	0.0268	0.0962	CrCrCtD
Medroxyprogesterone Acetate—Drospirenone—Spironolactone—dilated cardiomyopathy	0.0268	0.0962	CrCrCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Spironolactone—dilated cardiomyopathy	0.0255	0.0916	CrCrCtD
Medroxyprogesterone Acetate—Megestrol acetate—Spironolactone—dilated cardiomyopathy	0.0233	0.0838	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Spironolactone—dilated cardiomyopathy	0.0187	0.0673	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Spironolactone—dilated cardiomyopathy	0.0182	0.0652	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.0162	0.0582	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.0158	0.0566	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Spironolactone—dilated cardiomyopathy	0.0158	0.0566	CrCrCtD
Medroxyprogesterone Acetate—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.0158	0.0566	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0154	0.0552	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Spironolactone—dilated cardiomyopathy	0.0137	0.0492	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.0129	0.0462	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0123	0.051	CbGbCtD
Medroxyprogesterone Acetate—Benign breast neoplasm—Spironolactone—dilated cardiomyopathy	0.00422	0.107	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—cardial valve—dilated cardiomyopathy	0.00309	0.372	CbGeAlD
Medroxyprogesterone Acetate—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00121	0.0306	CcSEcCtD
Medroxyprogesterone Acetate—Glucose tolerance decreased—Furosemide—dilated cardiomyopathy	0.0012	0.0303	CcSEcCtD
Medroxyprogesterone Acetate—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.000799	0.0202	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—cardiac ventricle—dilated cardiomyopathy	0.000672	0.0807	CbGeAlD
Medroxyprogesterone Acetate—Infarction—Lisinopril—dilated cardiomyopathy	0.00065	0.0164	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—myocardium—dilated cardiomyopathy	0.000632	0.0759	CbGeAlD
Medroxyprogesterone Acetate—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.000521	0.0132	CcSEcCtD
Medroxyprogesterone Acetate—Breast pain—Spironolactone—dilated cardiomyopathy	0.000507	0.0128	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.000505	0.0128	CcSEcCtD
Medroxyprogesterone Acetate—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.000503	0.0127	CcSEcCtD
Medroxyprogesterone Acetate—Ulcer—Spironolactone—dilated cardiomyopathy	0.000468	0.0118	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—heart—dilated cardiomyopathy	0.000441	0.053	CbGeAlD
Medroxyprogesterone Acetate—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.000434	0.011	CcSEcCtD
Medroxyprogesterone Acetate—PGR—myocardium—dilated cardiomyopathy	0.000428	0.0514	CbGeAlD
Medroxyprogesterone Acetate—Eplerenone—NR3C2—dilated cardiomyopathy	0.000423	0.256	CrCbGaD
Medroxyprogesterone Acetate—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.000406	0.0103	CcSEcCtD
Medroxyprogesterone Acetate—Drospirenone—NR3C2—dilated cardiomyopathy	0.000406	0.245	CrCbGaD
Medroxyprogesterone Acetate—Leg pain—Lisinopril—dilated cardiomyopathy	0.000391	0.00988	CcSEcCtD
Medroxyprogesterone Acetate—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.000382	0.231	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—cardiac atrium—dilated cardiomyopathy	0.000377	0.0453	CbGeAlD
Medroxyprogesterone Acetate—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.000373	0.00944	CcSEcCtD
Medroxyprogesterone Acetate—AR—cardiac ventricle—dilated cardiomyopathy	0.000362	0.0436	CbGeAlD
Medroxyprogesterone Acetate—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.000358	0.00904	CcSEcCtD
Medroxyprogesterone Acetate—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.000356	0.00901	CcSEcCtD
Medroxyprogesterone Acetate—AR—myocardium—dilated cardiomyopathy	0.000341	0.041	CbGeAlD
Medroxyprogesterone Acetate—Thrombosis—Furosemide—dilated cardiomyopathy	0.00034	0.00859	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.00032	0.0484	CbGpPWpGaD
Medroxyprogesterone Acetate—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.000314	0.00794	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Spironolactone—dilated cardiomyopathy	0.000302	0.00763	CcSEcCtD
Medroxyprogesterone Acetate—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.000299	0.00757	CcSEcCtD
Medroxyprogesterone Acetate—PGR—heart—dilated cardiomyopathy	0.000299	0.0359	CbGeAlD
Medroxyprogesterone Acetate—Glycosuria—Furosemide—dilated cardiomyopathy	0.000297	0.00751	CcSEcCtD
Medroxyprogesterone Acetate—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.000297	0.0075	CcSEcCtD
Medroxyprogesterone Acetate—Injection site pain—Furosemide—dilated cardiomyopathy	0.000295	0.00745	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000289	0.00731	CcSEcCtD
Medroxyprogesterone Acetate—Spironolactone—NR3C2—dilated cardiomyopathy	0.000289	0.174	CrCbGaD
Medroxyprogesterone Acetate—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.000281	0.00711	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.00028	0.0424	CbGpPWpGaD
Medroxyprogesterone Acetate—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000274	0.00692	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—cardiac ventricle—dilated cardiomyopathy	0.000263	0.0315	CbGeAlD
Medroxyprogesterone Acetate—Heartburn—Lisinopril—dilated cardiomyopathy	0.000262	0.00663	CcSEcCtD
Medroxyprogesterone Acetate—Drug interaction—Furosemide—dilated cardiomyopathy	0.000259	0.00656	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00025	0.0378	CbGpPWpGaD
Medroxyprogesterone Acetate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000247	0.00625	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—myocardium—dilated cardiomyopathy	0.000247	0.0297	CbGeAlD
Medroxyprogesterone Acetate—AR—heart—dilated cardiomyopathy	0.000238	0.0286	CbGeAlD
Medroxyprogesterone Acetate—ESR1—heart—dilated cardiomyopathy	0.000234	0.0281	CbGeAlD
Medroxyprogesterone Acetate—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000221	0.00559	CcSEcCtD
Medroxyprogesterone Acetate—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000218	0.0055	CcSEcCtD
Medroxyprogesterone Acetate—Bladder pain—Furosemide—dilated cardiomyopathy	0.000218	0.0055	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00021	0.00531	CcSEcCtD
Medroxyprogesterone Acetate—Breast pain—Lisinopril—dilated cardiomyopathy	0.000207	0.00523	CcSEcCtD
Medroxyprogesterone Acetate—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000205	0.00519	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000205	0.00519	CcSEcCtD
Medroxyprogesterone Acetate—AR—cardiac atrium—dilated cardiomyopathy	0.000204	0.0245	CbGeAlD
Medroxyprogesterone Acetate—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000203	0.00512	CcSEcCtD
Medroxyprogesterone Acetate—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000202	0.0051	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—LAMA4—dilated cardiomyopathy	0.000202	0.0305	CbGpPWpGaD
Medroxyprogesterone Acetate—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000201	0.00508	CcSEcCtD
Medroxyprogesterone Acetate—Swelling—Furosemide—dilated cardiomyopathy	0.000198	0.005	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Spironolactone—dilated cardiomyopathy	0.000196	0.00496	CcSEcCtD
Medroxyprogesterone Acetate—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000195	0.00492	CcSEcCtD
Medroxyprogesterone Acetate—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000193	0.00489	CcSEcCtD
Medroxyprogesterone Acetate—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000192	0.00486	CcSEcCtD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00019	0.0288	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000188	0.0285	CbGpPWpGaD
Medroxyprogesterone Acetate—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000186	0.0047	CcSEcCtD
Medroxyprogesterone Acetate—SHBG—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.000186	0.0281	CbGpPWpGaD
Medroxyprogesterone Acetate—Thirst—Furosemide—dilated cardiomyopathy	0.000184	0.00464	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000183	0.00462	CcSEcCtD
Medroxyprogesterone Acetate—Purpura—Furosemide—dilated cardiomyopathy	0.000181	0.00458	CcSEcCtD
Medroxyprogesterone Acetate—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000181	0.00456	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00018	0.00456	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000179	0.00453	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000178	0.027	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000177	0.00448	CcSEcCtD
Medroxyprogesterone Acetate—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000176	0.00446	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Spironolactone—dilated cardiomyopathy	0.000174	0.00441	CcSEcCtD
Medroxyprogesterone Acetate—Cystitis—Lisinopril—dilated cardiomyopathy	0.000174	0.00441	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—heart—dilated cardiomyopathy	0.000172	0.0207	CbGeAlD
Medroxyprogesterone Acetate—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000171	0.00433	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—heart—dilated cardiomyopathy	0.000171	0.0205	CbGeAlD
Medroxyprogesterone Acetate—Irritability—Furosemide—dilated cardiomyopathy	0.000167	0.00421	CcSEcCtD
Medroxyprogesterone Acetate—Urinary retention—Furosemide—dilated cardiomyopathy	0.000166	0.0042	CcSEcCtD
Medroxyprogesterone Acetate—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000164	0.00414	CcSEcCtD
Medroxyprogesterone Acetate—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000163	0.00413	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Spironolactone—dilated cardiomyopathy	0.000163	0.00411	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.000161	0.0243	CbGpPWpGaD
Medroxyprogesterone Acetate—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00016	0.00403	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Spironolactone—dilated cardiomyopathy	0.000159	0.00402	CcSEcCtD
Medroxyprogesterone Acetate—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000159	0.00402	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000158	0.00399	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000157	0.00398	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—NR3C2—dilated cardiomyopathy	0.000156	0.0944	CrCbGaD
Medroxyprogesterone Acetate—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000154	0.0039	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000154	0.00389	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000152	0.00384	CcSEcCtD
Medroxyprogesterone Acetate—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000151	0.00381	CcSEcCtD
Medroxyprogesterone Acetate—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00015	0.00379	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—cardiac atrium—dilated cardiomyopathy	0.000147	0.0177	CbGeAlD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000147	0.0222	CbGpPWpGaD
Medroxyprogesterone Acetate—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000146	0.00369	CcSEcCtD
Medroxyprogesterone Acetate—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000145	0.00367	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000144	0.0218	CbGpPWpGaD
Medroxyprogesterone Acetate—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000141	0.00357	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Spironolactone—dilated cardiomyopathy	0.00014	0.00355	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000139	0.00352	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000137	0.0208	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000136	0.00344	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000136	0.00344	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000135	0.00342	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000135	0.0205	CbGpPWpGaD
Medroxyprogesterone Acetate—Drowsiness—Furosemide—dilated cardiomyopathy	0.000135	0.0034	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000134	0.0203	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000134	0.00339	CcSEcCtD
Medroxyprogesterone Acetate—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000134	0.00338	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000131	0.00331	CcSEcCtD
Medroxyprogesterone Acetate—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000131	0.00331	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00013	0.00329	CcSEcCtD
Medroxyprogesterone Acetate—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00013	0.00329	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Furosemide—dilated cardiomyopathy	0.000129	0.00326	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000127	0.00322	CcSEcCtD
Medroxyprogesterone Acetate—Face oedema—Lisinopril—dilated cardiomyopathy	0.000126	0.0032	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000126	0.0191	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Spironolactone—dilated cardiomyopathy	0.000125	0.00317	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Lisinopril—dilated cardiomyopathy	0.000125	0.00316	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000125	0.00315	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Lisinopril—dilated cardiomyopathy	0.000123	0.00311	CcSEcCtD
Medroxyprogesterone Acetate—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000123	0.0031	CcSEcCtD
Medroxyprogesterone Acetate—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00012	0.00303	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000119	0.00302	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000118	0.00299	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000118	0.00299	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000118	0.00298	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000117	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Furosemide—dilated cardiomyopathy	0.000116	0.00294	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000116	0.00294	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000114	0.00289	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Lisinopril—dilated cardiomyopathy	0.000113	0.00286	CcSEcCtD
Medroxyprogesterone Acetate—Asthma—Lisinopril—dilated cardiomyopathy	0.000113	0.00286	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Furosemide—dilated cardiomyopathy	0.000113	0.00285	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Furosemide—dilated cardiomyopathy	0.000113	0.00285	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000112	0.017	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Spironolactone—dilated cardiomyopathy	0.000112	0.00282	CcSEcCtD
Medroxyprogesterone Acetate—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000111	0.00282	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000111	0.0167	CbGpPWpGaD
Medroxyprogesterone Acetate—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00011	0.00279	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Furosemide—dilated cardiomyopathy	0.00011	0.00277	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000109	0.00276	CcSEcCtD
Medroxyprogesterone Acetate—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000109	0.00275	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000108	0.00273	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000107	0.0162	CbGpPWpGaD
Medroxyprogesterone Acetate—Dysuria—Lisinopril—dilated cardiomyopathy	0.000106	0.00268	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000105	0.00266	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Furosemide—dilated cardiomyopathy	0.000105	0.00266	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Furosemide—dilated cardiomyopathy	0.000105	0.00266	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Spironolactone—dilated cardiomyopathy	0.000104	0.00264	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Furosemide—dilated cardiomyopathy	0.000104	0.00262	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Lisinopril—dilated cardiomyopathy	0.000103	0.00261	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000103	0.0026	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000102	0.00259	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.000102	0.0155	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000102	0.00258	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000101	0.00256	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Lisinopril—dilated cardiomyopathy	0.000101	0.00255	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Spironolactone—dilated cardiomyopathy	0.0001	0.00254	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	9.95e-05	0.00252	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Spironolactone—dilated cardiomyopathy	9.95e-05	0.00251	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Spironolactone—dilated cardiomyopathy	9.94e-05	0.00251	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	9.9e-05	0.0025	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Lisinopril—dilated cardiomyopathy	9.9e-05	0.0025	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Spironolactone—dilated cardiomyopathy	9.88e-05	0.0025	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Lisinopril—dilated cardiomyopathy	9.84e-05	0.00249	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Lisinopril—dilated cardiomyopathy	9.82e-05	0.00248	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Furosemide—dilated cardiomyopathy	9.72e-05	0.00246	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Lisinopril—dilated cardiomyopathy	9.68e-05	0.00245	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Furosemide—dilated cardiomyopathy	9.66e-05	0.00244	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	9.55e-05	0.00241	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Lisinopril—dilated cardiomyopathy	9.52e-05	0.00241	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Lisinopril—dilated cardiomyopathy	9.47e-05	0.00239	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Furosemide—dilated cardiomyopathy	9.45e-05	0.00239	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Spironolactone—dilated cardiomyopathy	9.37e-05	0.00237	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Lisinopril—dilated cardiomyopathy	9.23e-05	0.00233	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Lisinopril—dilated cardiomyopathy	9.06e-05	0.00229	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Lisinopril—dilated cardiomyopathy	9e-05	0.00227	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	8.95e-05	0.00226	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Lisinopril—dilated cardiomyopathy	8.93e-05	0.00226	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	8.89e-05	0.00225	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Lisinopril—dilated cardiomyopathy	8.89e-05	0.00225	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Furosemide—dilated cardiomyopathy	8.76e-05	0.00221	CcSEcCtD
Medroxyprogesterone Acetate—AR—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	8.67e-05	0.0131	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Furosemide—dilated cardiomyopathy	8.65e-05	0.00219	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	8.58e-05	0.00217	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Lisinopril—dilated cardiomyopathy	8.57e-05	0.00217	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	8.52e-05	0.0129	CbGpPWpGaD
Medroxyprogesterone Acetate—Tinnitus—Lisinopril—dilated cardiomyopathy	8.45e-05	0.00214	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Furosemide—dilated cardiomyopathy	8.44e-05	0.00213	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Furosemide—dilated cardiomyopathy	8.42e-05	0.00213	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Furosemide—dilated cardiomyopathy	8.4e-05	0.00212	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Furosemide—dilated cardiomyopathy	8.34e-05	0.00211	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	8.3e-05	0.0021	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Lisinopril—dilated cardiomyopathy	8.22e-05	0.00208	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Furosemide—dilated cardiomyopathy	8.18e-05	0.00207	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	8.17e-05	0.00207	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Lisinopril—dilated cardiomyopathy	8.13e-05	0.00206	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	8.12e-05	0.0123	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Furosemide—dilated cardiomyopathy	8.02e-05	0.00203	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Lisinopril—dilated cardiomyopathy	8.01e-05	0.00202	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	8e-05	0.0121	CbGpPWpGaD
Medroxyprogesterone Acetate—Mental disorder—Lisinopril—dilated cardiomyopathy	7.94e-05	0.00201	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Lisinopril—dilated cardiomyopathy	7.89e-05	0.00199	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Lisinopril—dilated cardiomyopathy	7.89e-05	0.00199	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Lisinopril—dilated cardiomyopathy	7.78e-05	0.00197	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Lisinopril—dilated cardiomyopathy	7.74e-05	0.00196	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Lisinopril—dilated cardiomyopathy	7.73e-05	0.00195	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Furosemide—dilated cardiomyopathy	7.71e-05	0.00195	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Lisinopril—dilated cardiomyopathy	7.66e-05	0.00194	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Lisinopril—dilated cardiomyopathy	7.63e-05	0.00193	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Furosemide—dilated cardiomyopathy	7.63e-05	0.00193	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Lisinopril—dilated cardiomyopathy	7.59e-05	0.00192	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Furosemide—dilated cardiomyopathy	7.46e-05	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	7.41e-05	0.00187	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Furosemide—dilated cardiomyopathy	7.4e-05	0.00187	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Lisinopril—dilated cardiomyopathy	7.39e-05	0.00187	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Furosemide—dilated cardiomyopathy	7.34e-05	0.00186	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	7.32e-05	0.00185	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Lisinopril—dilated cardiomyopathy	7.29e-05	0.00184	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Lisinopril—dilated cardiomyopathy	7.21e-05	0.00182	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	7.15e-05	0.0108	CbGpPWpGaD
Medroxyprogesterone Acetate—Malaise—Lisinopril—dilated cardiomyopathy	7.12e-05	0.0018	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Lisinopril—dilated cardiomyopathy	7.09e-05	0.00179	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Lisinopril—dilated cardiomyopathy	7.08e-05	0.00179	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Furosemide—dilated cardiomyopathy	7.07e-05	0.00179	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	7.04e-05	0.0106	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	7.02e-05	0.00177	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Lisinopril—dilated cardiomyopathy	6.97e-05	0.00176	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Lisinopril—dilated cardiomyopathy	6.94e-05	0.00175	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Furosemide—dilated cardiomyopathy	6.82e-05	0.00172	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Furosemide—dilated cardiomyopathy	6.79e-05	0.00172	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Furosemide—dilated cardiomyopathy	6.79e-05	0.00172	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Lisinopril—dilated cardiomyopathy	6.72e-05	0.0017	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Lisinopril—dilated cardiomyopathy	6.72e-05	0.0017	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Lisinopril—dilated cardiomyopathy	6.72e-05	0.0017	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Lisinopril—dilated cardiomyopathy	6.69e-05	0.00169	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	6.67e-05	0.00169	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.64e-05	0.01	CbGpPWpGaD
Medroxyprogesterone Acetate—Discomfort—Lisinopril—dilated cardiomyopathy	6.64e-05	0.00168	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.62e-05	0.01	CbGpPWpGaD
Medroxyprogesterone Acetate—Dry mouth—Lisinopril—dilated cardiomyopathy	6.57e-05	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Lisinopril—dilated cardiomyopathy	6.49e-05	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Cellular roles of Anthrax toxin—TNF—dilated cardiomyopathy	6.49e-05	0.00981	CbGpPWpGaD
Medroxyprogesterone Acetate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	6.44e-05	0.00163	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Lisinopril—dilated cardiomyopathy	6.44e-05	0.00163	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Lisinopril—dilated cardiomyopathy	6.4e-05	0.00162	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	6.35e-05	0.0096	CbGpPWpGaD
Medroxyprogesterone Acetate—Shock—Lisinopril—dilated cardiomyopathy	6.34e-05	0.0016	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Furosemide—dilated cardiomyopathy	6.32e-05	0.0016	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	6.31e-05	0.00159	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Lisinopril—dilated cardiomyopathy	6.29e-05	0.00159	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Lisinopril—dilated cardiomyopathy	6.26e-05	0.00158	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.24e-05	0.00944	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	6.23e-05	0.00157	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Furosemide—dilated cardiomyopathy	6.16e-05	0.00156	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Lisinopril—dilated cardiomyopathy	6.14e-05	0.00155	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Furosemide—dilated cardiomyopathy	6.07e-05	0.00154	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	6.07e-05	0.00918	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Lisinopril—dilated cardiomyopathy	6.02e-05	0.00152	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ANKRD1—dilated cardiomyopathy	5.99e-05	0.00905	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Furosemide—dilated cardiomyopathy	5.87e-05	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	5.87e-05	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Lisinopril—dilated cardiomyopathy	5.82e-05	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Lisinopril—dilated cardiomyopathy	5.78e-05	0.00146	CcSEcCtD
Medroxyprogesterone Acetate—AR—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	5.75e-05	0.0087	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Lisinopril—dilated cardiomyopathy	5.74e-05	0.00145	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Lisinopril—dilated cardiomyopathy	5.73e-05	0.00145	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Furosemide—dilated cardiomyopathy	5.68e-05	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Lisinopril—dilated cardiomyopathy	5.67e-05	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—TAZ—dilated cardiomyopathy	5.63e-05	0.00851	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Lisinopril—dilated cardiomyopathy	5.6e-05	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	5.56e-05	0.00141	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Lisinopril—dilated cardiomyopathy	5.55e-05	0.0014	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Lisinopril—dilated cardiomyopathy	5.51e-05	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Furosemide—dilated cardiomyopathy	5.46e-05	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Furosemide—dilated cardiomyopathy	5.41e-05	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Furosemide—dilated cardiomyopathy	5.41e-05	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Furosemide—dilated cardiomyopathy	5.38e-05	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	5.31e-05	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	5.27e-05	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	5.17e-05	0.00782	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Lisinopril—dilated cardiomyopathy	5.12e-05	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	5.1e-05	0.00771	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Furosemide—dilated cardiomyopathy	5.1e-05	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Lisinopril—dilated cardiomyopathy	5.09e-05	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Lisinopril—dilated cardiomyopathy	5.09e-05	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SDHA—dilated cardiomyopathy	5.09e-05	0.0077	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	4.74e-05	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Lisinopril—dilated cardiomyopathy	4.62e-05	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	4.58e-05	0.00692	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	4.57e-05	0.00691	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Lisinopril—dilated cardiomyopathy	4.56e-05	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	4.5e-05	0.00681	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Lisinopril—dilated cardiomyopathy	4.41e-05	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	4.32e-05	0.00653	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Lisinopril—dilated cardiomyopathy	4.26e-05	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Lisinopril—dilated cardiomyopathy	4.09e-05	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Lisinopril—dilated cardiomyopathy	4.06e-05	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Lisinopril—dilated cardiomyopathy	4.06e-05	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Lisinopril—dilated cardiomyopathy	4.03e-05	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	3.96e-05	0.00599	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	3.94e-05	0.00597	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	3.9e-05	0.0059	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Lisinopril—dilated cardiomyopathy	3.83e-05	0.000967	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	3.75e-05	0.00567	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	3.73e-05	0.00564	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	3.72e-05	0.00563	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	3.65e-05	0.00552	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	3.65e-05	0.00552	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	3.53e-05	0.00533	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	3.47e-05	0.00525	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	3.33e-05	0.00503	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	3.3e-05	0.00498	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	3.29e-05	0.00497	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	3.28e-05	0.00496	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.23e-05	0.00489	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	3.12e-05	0.00473	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.1e-05	0.00469	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.02e-05	0.00457	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	3.02e-05	0.00456	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ANKRD1—dilated cardiomyopathy	2.96e-05	0.00447	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TAZ—dilated cardiomyopathy	2.78e-05	0.0042	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.72e-05	0.00412	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	2.71e-05	0.0041	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	2.71e-05	0.0041	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	2.53e-05	0.00383	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SDHA—dilated cardiomyopathy	2.51e-05	0.0038	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	2.5e-05	0.00377	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	2.45e-05	0.00371	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	2.44e-05	0.0037	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	2.37e-05	0.00358	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.22e-05	0.00335	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	2.19e-05	0.0033	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.14e-05	0.00324	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	2.13e-05	0.00322	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—RAF1—dilated cardiomyopathy	2.12e-05	0.0032	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.11e-05	0.00319	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NR3C2—dilated cardiomyopathy	2.08e-05	0.00314	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	2.07e-05	0.00312	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.07e-05	0.00312	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	2.06e-05	0.00311	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.03e-05	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	2e-05	0.00302	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	1.88e-05	0.00285	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.87e-05	0.00282	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.75e-05	0.00265	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	1.7e-05	0.00257	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.65e-05	0.0025	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	1.62e-05	0.00245	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	1.59e-05	0.00241	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.59e-05	0.00241	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NR3C2—dilated cardiomyopathy	1.58e-05	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	1.57e-05	0.00237	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.56e-05	0.00236	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NPPA—dilated cardiomyopathy	1.54e-05	0.00232	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.53e-05	0.00232	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.52e-05	0.0023	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.49e-05	0.00226	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PSEN2—dilated cardiomyopathy	1.49e-05	0.00225	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—dilated cardiomyopathy	1.45e-05	0.00219	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.43e-05	0.00216	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GPX1—dilated cardiomyopathy	1.38e-05	0.00209	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CD36—dilated cardiomyopathy	1.35e-05	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.34e-05	0.00203	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.34e-05	0.00203	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NPPA—dilated cardiomyopathy	1.31e-05	0.00197	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	1.24e-05	0.00188	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	1.22e-05	0.00184	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AGT—dilated cardiomyopathy	1.21e-05	0.00183	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	1.2e-05	0.00182	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	1.11e-05	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.04e-05	0.00158	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.03e-05	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.03e-05	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NPPA—dilated cardiomyopathy	9.94e-06	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.25e-06	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.25e-06	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.21e-06	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	9.05e-06	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.77e-06	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.6e-06	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	8.56e-06	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	8.52e-06	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.33e-06	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	8.31e-06	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.22e-06	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	7.82e-06	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	7.81e-06	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	7.66e-06	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	7.54e-06	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RAC1—dilated cardiomyopathy	7.48e-06	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.3e-06	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.3e-06	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.11e-06	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.09e-06	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	7.07e-06	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GPX1—dilated cardiomyopathy	6.83e-06	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.78e-06	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	6.76e-06	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.76e-06	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.75e-06	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CD36—dilated cardiomyopathy	6.65e-06	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.57e-06	0.000994	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	6.36e-06	0.000962	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AGT—dilated cardiomyopathy	5.99e-06	0.000905	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.8e-06	0.000877	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	5.75e-06	0.00087	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.61e-06	0.000849	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.32e-06	0.000805	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RAC1—dilated cardiomyopathy	5.24e-06	0.000792	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AGT—dilated cardiomyopathy	5.01e-06	0.000757	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RAF1—dilated cardiomyopathy	4.96e-06	0.00075	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.82e-06	0.00073	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.57e-06	0.000692	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.46e-06	0.000675	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.31e-06	0.000652	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.28e-06	0.000648	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.28e-06	0.000648	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.2e-06	0.000635	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.19e-06	0.000634	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RAC1—dilated cardiomyopathy	4.13e-06	0.000625	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.98e-06	0.000602	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AGT—dilated cardiomyopathy	3.95e-06	0.000597	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.86e-06	0.000583	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.79e-06	0.000574	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.78e-06	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.51e-06	0.000531	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RAF1—dilated cardiomyopathy	3.47e-06	0.000525	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.42e-06	0.000517	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—dilated cardiomyopathy	3.4e-06	0.000515	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.29e-06	0.000498	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.12e-06	0.000473	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.08e-06	0.000465	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RAF1—dilated cardiomyopathy	2.74e-06	0.000414	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.68e-06	0.000406	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.43e-06	0.000367	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—dilated cardiomyopathy	2.38e-06	0.00036	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	2.32e-06	0.00035	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.92e-06	0.00029	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—dilated cardiomyopathy	1.88e-06	0.000284	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.87e-06	0.000283	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.68e-06	0.000255	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.61e-06	0.000243	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.56e-06	0.000236	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.52e-06	0.00023	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.37e-06	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.1e-06	0.000167	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.03e-06	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1e-06	0.000152	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	9.04e-07	0.000137	CbGpPWpGaD
